BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 5,560.00
+30.00 (0.54%)
At close: Nov 5, 2025
BioNote Market Cap
BioNote has a market cap or net worth of 563.57 billion as of November 5, 2025. Its market cap has increased by 17.87% in one year.
Market Cap
563.57B
Enterprise Value
214.51B
Revenue
112.04B
Ranking
n/a
PE Ratio
4.70
Stock Price
5,560.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 563.57B, a decrease of -48.06%. That is a compound annual growth rate of -20.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 563.57B | 17.24% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1.08T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 56.52T |
| Celltrion | 38.68T |
| ALTEOGEN | 26.13T |
| SK Biopharmaceuticals | 9.05T |
| Yuhan | 8.83T |
| HLB Co., Ltd. | 6.38T |
| Peptron | 6.31T |
| PharmaResearch | 5.62T |